Invivyd (IVVD) Accumulated Expenses (2020 - 2025)

Invivyd (IVVD) reported Accumulated Expenses of $19.1 million for Q4 2025, down 62.04% on a YoY basis from $50.2 million in Q4 2024, and down 24.62% quarter-over-quarter from $25.3 million in Q3 2025.

Invivyd (IVVD) Accumulated Expenses (2020 - 2025) Analysis & Trends

Invivyd has reported Accumulated Expenses for 6 years, with the latest figure at $19.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 62.04% year-over-year to $19.1 million; the trailing twelve-month figure through Dec 2025 stood at $19.1 million (down 62.04% YoY), and the FY2025 full-year result was $19.1 million, down 62.04% from the prior year.
  • Accumulated Expenses for Q4 2025 stood at $19.1 million, down from $25.3 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $76.5 million in Q1 2022, with the low at $14.5 million in Q1 2023.
  • Historically, Accumulated Expenses has averaged $35.6 million across 5 years, with a median of $29.0 million in 2022.
  • Annual changes were most pronounced in 2021 — Accumulated Expenses jumped 1044.07% — and 2023, when it tumbled 81.05%.
  • Invivyd's Accumulated Expenses stood at $56.3 million in 2021, then slumped by 61.07% to $21.9 million in 2022, then surged by 86.48% to $40.9 million in 2023, then increased by 22.85% to $50.2 million in 2024, then tumbled by 62.04% to $19.1 million in 2025.
  • The last three Accumulated Expenses figures came in at $19.1 million (Q4 2025), $25.3 million (Q3 2025), and $25.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Invivyd 168.41 Mn -58.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 19.05 Mn
Sep 30, 2025 25.28 Mn
Jun 30, 2025 25.31 Mn
Mar 31, 2025 39.93 Mn
Dec 31, 2024 50.20 Mn
Sep 30, 2024 59.40 Mn
Jun 30, 2024 26.82 Mn
Mar 31, 2024 34.00 Mn
Dec 31, 2023 40.86 Mn
Sep 30, 2023 15.96 Mn
Jun 30, 2023 26.74 Mn
Mar 31, 2023 14.50 Mn
Dec 31, 2022 21.91 Mn
Sep 30, 2022 28.97 Mn
Jun 30, 2022 52.62 Mn
Mar 31, 2022 76.54 Mn
Dec 31, 2021 56.28 Mn
Sep 30, 2021 35.49 Mn
Jun 30, 2021 27.18 Mn
Dec 31, 2020 4.92 Mn